U.S., Oct. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07891065) titled 'EEG As a Genetic Selection Lever in Autism Spectrum Disorder' on Sept. 29.
Brief Summary: Autism Spectrum Disorder (ASD) is a growing public health concern, with genetic causes identified in about 20% of cases. While exome/genome sequencing is powerful, its cost and limited yield call for better patient selection.
Electroencephalography (EEG) shows promise: early EEG patterns can predict ASD, and specific EEG features may help identify subgroups more likely to have a genetic cause. This project explores using EEG to optimize genetic testing strategies in ASD.
Study Start Date: Sept., 2026
Study Type: OBSERVATIONAL
Condition:
Au...